NCT06048497

Brief Summary

It has been reported that corrected carotid flow time (FTc) may indicate the responsiveness of spontaneously breathing patients to fluid therapy. The primary objective of the study is to determine the effect of fluid preload applied to patients with preanesthetic FTc values below the cut-off value on the incidence of hypotension in cesarean section (C/S) surgery. Pregnant women who underwent cesarean section under spinal anesthesia were included in this prospective study. In the preoperative care unit, patients were assigned to two groups according to their baseline FTc values. Patients with baseline FTc \< 327 ms were assigned to the first group, and Ringer Lactate (RL) preload fluid administration to these patients was continued until FTc \> 327 ms. On the other hand, patients with baseline FTc \> 327 ms were assigned to the second group, and preload fluid was not administered to these patients. Intraoperative hemodynamic data were recorded for each patient.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2022

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 15, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 5, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 15, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 21, 2023

Completed
Last Updated

September 28, 2023

Status Verified

September 1, 2023

Enrollment Period

6 months

First QC Date

September 15, 2023

Last Update Submit

September 25, 2023

Conditions

Keywords

Cesarean sectionCarotid flow timePreload fluidHypotensionSpinal anesthesia

Outcome Measures

Primary Outcomes (1)

  • The incidence of intra-operative hypotension

    Hypotension definitions included systolic arterial pressure (SAP) below 80 mmHg, or mean arterial pressure (MAP) below 65 mmHg, or a decrease in SAP of more than 30% below baseline, or a decrease in MAP of more than 20% below baseline, or any combination of all these definitions.

    During surgery

Study Arms (2)

Preload

Patients with baseline FTc \< 327 ms were assigned to the preload group, and Ringer Lactate (RL) preload fluid administration to these patients was continued until FTc \> 327 ms.

Device: Corrected carotid flow time measurement guided fluid preload

Non-preload

Patients with baseline FTc \> 327 ms were assigned to the non-preload group, and preload fluid was not administered to these patients

Interventions

Preoperative FTcs of pregnant women who underwent C/S operation were measured, and those below the cut-off value (327 ms) determined in previous studies were preloaded with Ringer Lactate until FTc was \> 327 ms.

Preload

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

ASA II pregnant women between the ages of 20 and 40 who were undergoing elective cesarean section, and had uncomplicated singleton term pregnancies, and agreed to participate in the study were included.

You may qualify if:

  • years of age pregnant women
  • American Society of Anesthesiologists (ASA) physical status-II patients
  • Uncomplicated, singleton, term pregnancy
  • Elective C/S surgery

You may not qualify if:

  • Placental disorders
  • Gestational hypertensive disorders
  • Morbid obesity (BMI\>39 kg/m2)
  • Carotid stenosis more than 50%
  • Baseline SAP more than 160 mmHg
  • Arrhythmia
  • History of cardiovascular or cerebrovascular disease, and chronic kidney disease (estimated glomerular filtration rate \<60 mL/min/1.73 m2)
  • Emergency surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Cukurova University

Adana, Saricam, 01330, Turkey (Türkiye)

Location

Çukurova University; Faculty of Medicine

Adana, Sarıçam, 01330, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Hypotension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Demet Laflı Tunay, Dr.

    Çukurova University, Balcalı Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 15, 2023

First Posted

September 21, 2023

Study Start

November 15, 2022

Primary Completion

May 20, 2023

Study Completion

July 5, 2023

Last Updated

September 28, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

All data were anonymized by the local researcher. Therefore, data collection was pseudonymous and the patient's name did not appear on any case report form or other study document. All collected data were kept confidential. This study was conducted in accordance with the revision of the Declaration of Helsinki (2008). International Conference on Harmonisation-Good Clinical Practice (ICH-GCP) was strictly adhered to.

Locations